Elon Musk's Neuralink plans to begin mass production of its brain chips in 2026, aiming to increase accessibility and affordability. The company is also developing an automated surgical system to implant the chips, which are designed to translate brain signals into digital commands. This technology primarily seeks to aid individuals with paralysis or neurological conditions, potentially restoring independence through thought-controlled devices. Human trials have commenced following regulatory approval.